In the Media Tag: Amber Thacker

UT Health Science Center researchers impressed by early participation in Regeneron COVID-19 treatment drug study

In the Media Icon

Doctors at University of Tennessee Health Science Center said their COVID-19 treatment study is already off to a better than expected and positive start.Researchers are seeing how well a COVID-19 treatment drug works with the area’s diverse population.

Local, but often forgotten institution is about to start clinical trials for a drug to fight COVID-19

In the Media Icon

University of Tennessee’s Health Science Center is turning heads. Way before the pandemic, its gene research and mobile stroke unit were groundbreaking. Now we learn in addition to hoping to come up with a vaccine, Researchers will also be conducting clinical trials for a drug that can fight COVID-19.

Regional One, UTHSC are conducting COVID-19 clinical trials and they need Memphis volunteers

The Commercial Appeal

A new potential COVID-19-fighting drug is being tested in Memphis. Researchers on the clinical trials hope the drug will help treat people with COVID-19 who do not require hospitalization and prevent infection among people who have had close contact with someone who tested positive. Regional One Health and the University of Tennessee Health Science Center… Read More

Health Care Heroes In Unprecedented Times: Dr. Amber Thacker, UTHSC/Regional One Health

The Memphis Business Journal

For Dr. Amber Thacker, going into medicine was more or less second nature. As a kid, she would buy old medical and science textbooks. She set up a lab in her closet.